NuStar Energy LP
Change company Symbol lookup
Select an option...
NS NuStar Energy LP
DOCU DocuSign Inc
VHUB Vapor Hub International Inc
VMC Vulcan Materials Co
VLO Valero Energy Corp
VIAC ViacomCBS Inc
VFC VF Corp
VECO Veeco Instruments Inc
VALE Vale SA
V Visa Inc
Go

Energy : Oil, Gas & Consumable Fuels | Small Cap Value
Company profile

NuStar Energy L.P. is engaged in the transportation of petroleum products and anhydrous ammonia; the terminalling and storage of petroleum products, and the marketing of petroleum products. The Company's segments include pipeline, storage and fuels marketing. The pipeline segment consists of the transportation of refined petroleum products, crude oil and anhydrous ammonia. The storage segment consists of facilities that provide storage, handling and other services for petroleum products, crude oil, specialty chemicals and other liquids. The fuels marketing segment involve the purchase of crude oil, fuel oil, bunker fuel, fuel oil blending components and other refined products for resale. It conducts its operations through its subsidiaries, primarily NuStar Logistics, L.P. and NuStar Pipeline Operating Partnership L.P. It has approximately 10,000 miles of pipeline and 73 terminal and storage facilities that provide approximately 72 million barrels of storage capacity.

Price
Delayed
$18.26
Day's Change
-0.31 (-1.67%)
Bid
--
Ask
--
B/A Size
--
Day's High
18.74
Day's Low
18.10
Volume
(Below Average)

Today's volume of 255,412 shares is on pace to be lower than NS's 10-day average volume of 447,379 shares.

255,412

(OCGN) Alert: Did You Lose Money on Your Ocugen Investment? Contact Johnson Fistel Regarding Investigation

10:27 am ET June 10, 2021 (PR Newswire) Print

Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of the federal securities laws by Ocugen, Inc. ("Ocugen" or the "Company") (NASDAQ: OCGN).

On May 26, 2021, Ocugen announced its plan to submit an Emergency Use Authorization (EUA) application for COVAXIN, a COVID-19 vaccine, to the U.S. Food & Drug Administration (FDA) in June 2021.

Then on June 10, 2021, the Company said it would no longer pursue a EUA for Covaxin and would instead aim to file for a full U.S. approval of the shot.

Following this news, the price of Ocugen common shares fell over 20% in early morning trading on June 10, 2021

If you have information that could assist in this investigation, including past employees and others, or if you are an Ocugen shareholder and are interested in learning more about the investigation, please contact Jim Baker (jimb@johnsonfistel.com) by email or phone at 619-814-4471. If emailing, please include a phone number.

Additionally, you can [click here to join this action]. There is no cost or obligation to you.

About Johnson Fistel, LLP:Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com. Attorney advertising. Past results do not guarantee future outcomes.

Contact:Johnson Fistel, LLPJim Baker, 619-814-4471jimb@johnsonfistel.com

[click here to join this action]

https://c212.net/c/img/favicon.png?sn=PH07348&sd=2021-06-10

View original content:http://www.prnewswire.com/news-releases/ocgn-alert-did-you-lose-money-on-your-ocugen-investment-contact-johnson-fistel-regarding-investigation-301310179.html

SOURCE Johnson Fistel, LLP

https://rt.prnewswire.com/rt.gif?NewsItemId=PH07348&Transmission_Id=202106101027PR_NEWS_USPR_____PH07348&DateId=20210610

comtex tracking

COMTEX_388097413/1005/2021-06-10T10:27:48

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.